Cite Filings / RIGL / 0000895421-24-000137
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G

Amended Statement of Ownership

RIGEL PHARMACEUTICALS INC · Filed 2024-02-09 · Acc 0000895421-24-000137

Documents 1

  • SC 13G Amended Statement of Ownership , RigelPharmIncRIGL.txt

Around this filing

  • 2024-11-08 SC 13G Amended Statement of Ownership
  • 2024-02-09 SC 13G Amended Statement of Ownership
  • 2024-02-06 4 EVP, Chief Commercial Officer sold 14,519 shares at an average $1.14 ($16,496)
  • 2024-02-06 4 EVP & Chief Financial Officer sold 12,628 shares at an average $1.14 ($14,338)
  • 2024-02-06 4 CEO, President sold 52,894 shares at an average $1.14 ($60,082)
  • 2024-02-05 SC 13G/A Amended Statement of Ownership
  • 2023-02-22 SC 13G Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Armistice Capital, LLC 8.22%
  2. 2026-11-16 SCHEDULE 13G · American Century Investment Management, Inc. 5.6%
  3. 2026-11-13 SCHEDULE 13G · Morgan Stanley 6.5%
Loading RigelPharmIncRIGL.txt…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…